Advertisement
UK markets open in 5 hours 58 minutes
  • NIKKEI 225

    38,288.32
    +85.95 (+0.22%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • CRUDE OIL

    79.33
    +0.34 (+0.43%)
     
  • GOLD FUTURES

    2,317.00
    -5.30 (-0.23%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • Bitcoin GBP

    49,140.65
    -966.66 (-1.93%)
     
  • CMC Crypto 200

    1,307.96
    +13.29 (+1.03%)
     
  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

Have Investors Priced In Community Health Systems Inc’s (NYSE:CYH) Growth?

Community Health Systems Inc (NYSE:CYH), a healthcare company based in United States, received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to $5.09 at one point, and dropping to the lows of $3.71. This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether Community Health Systems’s current trading price of $4.01 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Community Health Systems’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change. See our latest analysis for Community Health Systems

What is Community Health Systems worth?

Great news for investors – Community Health Systems is still trading at a fairly cheap price. My valuation model shows that the intrinsic value for the stock is $47.81, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Community Health Systems’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Community Health Systems?

NYSE:CYH Future Profit June 27th 18
NYSE:CYH Future Profit June 27th 18

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Community Health Systems’s earnings over the next few years are expected to increase by 98.85%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? Since CYH is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on CYH for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy CYH. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Community Health Systems. You can find everything you need to know about Community Health Systems in the latest infographic research report. If you are no longer interested in Community Health Systems, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.